Showing results (141-150 of 304) with videos related to

Sort By:
Pageof 31
APMIS. Supplementum|January 1, 1988
Neuroendocrine activity in metastatic breast carcinomasJ M Nesland, R Holm, L Ottestad, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 19, 2011
The impact of acquisition angle differences on three-dimensional quantitative coronary angiographyShengxian Tu, Niels R Holm, Gerhard Koning, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancerM Baekelandt, R Holm, C G Tropé, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
High incidence of human papillomavirus in 146 cervical carcinomas. A study using three different pairs of consensus primers, and detecting viral genomes with putative deletionsF Karlsen, G Kristensen, R Holm, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Allelic imbalance at chromosome region 11q23 in cervical carcinomasH Skomedal, A Helland, G B Kristensen, et al.
JAMA|February 27, 1978
Clostridial myonecrosis ('gas gangrene') during cephalosporin prophylaxisJ A Mohr, W Griffiths, R Holm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical studyM Baekelandt, R Holm, C G Tropé, et al.
Anticancer Research|January 29, 2000
Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancerM Baekelandt, G B Kristensen, C G Tropé, et al.
The Journal of Pathology|December 18, 2001
Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcomeV A Flørenes, G M Maelandsmo, R Faye, et al.
The American Journal of Pathology|December 1, 1996
Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesionsG M Maelandsmo, R Holm, O Fodstad, et al.
Pageof 31